Display Settings:

Format

Send to:

Choose Destination
J Clin Oncol. 2007 Oct 1;25(28):4506-7; author reply 4508.

Does a statistically significant survival benefit of erlotinib plus gemcitabine for advanced pancreatic cancer translate into clinical significance and value?

Comment on

PMID:
17906218
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for HighWire
    Write to the Help Desk